These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8709234)

  • 41. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells.
    Simon JH; Fouchier RA; Southerling TE; Guerra CB; Grant CK; Malim MH
    J Virol; 1997 Jul; 71(7):5259-67. PubMed ID: 9188594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.
    Chowdhury IH; Chao W; Potash MJ; Sova P; Gendelman HE; Volsky DJ
    J Virol; 1996 Aug; 70(8):5336-45. PubMed ID: 8764044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
    Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
    J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
    Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?
    Bour S; Schubert U; Peden K; Strebel K
    J Virol; 1996 Feb; 70(2):820-9. PubMed ID: 8551620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity.
    Sakai K; Ma XY; Gordienko I; Volsky DJ
    J Virol; 1991 Nov; 65(11):5765-73. PubMed ID: 1920615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release.
    Bour S; Strebel K
    Microbes Infect; 2003 Sep; 5(11):1029-39. PubMed ID: 12941395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
    von Schwedler U; Song J; Aiken C; Trono D
    J Virol; 1993 Aug; 67(8):4945-55. PubMed ID: 8331734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
    Huang M; Orenstein JM; Martin MA; Freed EO
    J Virol; 1995 Nov; 69(11):6810-8. PubMed ID: 7474093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.
    Yao XJ; Subbramanian RA; Rougeau N; Boisvert F; Bergeron D; Cohen EA
    J Virol; 1995 Nov; 69(11):7032-44. PubMed ID: 7474123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
    Schröfelbauer B; Senger T; Manning G; Landau NR
    J Virol; 2006 Jun; 80(12):5984-91. PubMed ID: 16731937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region.
    Baraz L; Hutoran M; Blumenzweig I; Katzenellenbogen M; Friedler A; Gilon C; Steinitz M; Kotler M
    J Gen Virol; 2002 Sep; 83(Pt 9):2225-2230. PubMed ID: 12185277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors.
    Simm M; Pekarskaya O; Potash MJ; Volsky DJ
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):943-52. PubMed ID: 10890355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing.
    Schwartz S; Felber BK; Pavlakis GN
    Virology; 1991 Aug; 183(2):677-86. PubMed ID: 1830183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
    Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.
    Lu YL; Bennett RP; Wills JW; Gorelick R; Ratner L
    J Virol; 1995 Nov; 69(11):6873-9. PubMed ID: 7474102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of Vif during HIV-1 infection: interaction with novel host cellular factors.
    Lake JA; Carr J; Feng F; Mundy L; Burrell C; Li P
    J Clin Virol; 2003 Feb; 26(2):143-52. PubMed ID: 12600646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest.
    Sakai K; Dimas J; Lenardo MJ
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3369-74. PubMed ID: 16492778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent insights into HIV-1 Vif.
    Navarro F; Landau NR
    Curr Opin Immunol; 2004 Aug; 16(4):477-82. PubMed ID: 15245742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase.
    Welker R; Kottler H; Kalbitzer HR; Kräusslich HG
    Virology; 1996 May; 219(1):228-36. PubMed ID: 8623533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.